Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. CellSource Co., Ltd.
  6. Summary
    4880   JP3423580004

CELLSOURCE CO., LTD.

(4880)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Japan Exchange
01/24/2022 01/25/2022 01/26/2022 01/27/2022 01/28/2022 Date
4225(c) 3860(c) 3960(c) 3540(c) 3565(c) Last
155 300 332 900 129 000 355 700 174 200 Volume
+0.12% -8.64% +2.59% -10.61% +0.71% Change
More quotes
Estimated financial data (e)
Sales 2021 2 904 M 25,2 M 25,2 M
Net income 2021 575 M 4,99 M 4,99 M
Net Debt 2021 - - -
P/E ratio 2021 115x
Yield 2021 -
Sales 2022 3 792 M 32,9 M 32,9 M
Net income 2022 786 M 6,82 M 6,82 M
Net Debt 2022 - - -
P/E ratio 2022 84,3x
Yield 2022 -
Capitalization 66 403 M 577 M 576 M
Capi. / Sales 2021 22,9x
Capi. / Sales 2022 17,5x
Nbr of Employees 68
Free-Float 28,3%
More Financials
Company
CellSource Co., Ltd. is a Japan-based company engaged in regenerative medicine related business and consumer business. The Company operates in two business segments. The Regenerative Medicine Related business segment is engaged in the provision of contracted services for processing tissues and cells derived from fat and blood to medical institutions, and support services for regenerative medicine laws and... 
More about the company
Ratings of CellSource Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about CELLSOURCE CO., LTD.
2020CELLSOURCE CO., LTD.(TSE : 4880) added to S&P Global BMI Index
CI
2020Certain Common Stock of CellSource Co., Ltd. are subject to a Lock-Up Agreement Ending ..
CI
2019CellSource Co., Ltd. has completed an IPO in the amount of ¥1.0944 billion.
CI
2019CellSource Co., Ltd. has filed an IPO.
CI
More news
News in other languages on CELLSOURCE CO., LTD.

- No features available -

More news
Chart CELLSOURCE CO., LTD.
Duration : Period :
CellSource Co., Ltd. Technical Analysis Chart | 4880 | JP3423580004 | MarketScreener
Technical analysis trends CELLSOURCE CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 3 565,00 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Masato Tsumamoto President, CEO & Representative Director
Takeshi Amemiya Chief Financial Officer & Director
Katsuji Onishi Executive Officer & GM-Business Administration
Norio Murakami Independent Outside Director
Hirohiko Hanaki Director & Chief Compliance Officer
Sector and Competitors